Partial Dopamine Agonists and the Treatment of Psychosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|3|1|3-8

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.3, Iss.1, 2005-01, pp. : 3-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Partial Dopamine Agonists and Dopaminergic Stabilizers, in the Treatment of Psychosis

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 2, 2002-04 ,pp. : 141-147

Bentham Science Publishers

Access to resources Recommend Favorite

D2 Receptor Partial Agonists: Treatment of CNS Disorders of Dopamine Function

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 12, 2008-08 ,pp. : 1068-1088

Bentham Science Publishers

Access to resources Recommend Favorite

Partial Dopamine Receptor Agonists as Newer Atypical Antipsychotics:Intrinsic Activity Appropriate for Treatment of Schizophrenic Patients

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 7, Iss. 3, 2007-09 ,pp. : 156-165

Bentham Science Publishers

Access to resources Recommend Favorite

Dopamine Partial Agonists: A New Class of Antipsychotic

By Lieberman J.A.  

CNS Drugs, Vol. 18, Iss. 4, 2004-01 ,pp. : 251-267

Adis International

Access to resources Recommend Favorite

The safety of dopamine agonists in the treatment of Parkinson's disease

By Bonuccelli Ubaldo   Ceravolo Roberto  

Expert Opinion on Drug Safety, Vol. 7, Iss. 2, 2008-03 ,pp. : 111-127

Informa Healthcare

Access to resources Recommend Favorite